Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNB2 | O95067 | 2/20 | 0.59 |
| ▸ | CDK1 | P06493 | 2/20 | 0.59 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.59 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.59 |
| ▸ | AURKA | O14965 | 8/20 | 0.56 |
| ▸ | RPS6KB1 | P23443 | 7/20 | 0.56 |
| ▸ | AURKB | Q96GD4 | 4/20 | 0.56 |
| ▸ | CDC7 | O00311 | 1/20 | 0.48 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.48 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.48 |
| ▸ | JAK2 | O60674 | 1/20 | 0.48 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.48 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.48 |
| ▸ | PAK4 | O96013 | 1/20 | 0.48 |
| ▸ | ABL1 | P00519 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | CSF1R | P07333 | 1/20 | 0.48 |
| ▸ | RET | P07949 | 1/20 | 0.48 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.48 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30605167 | 1.00 | CCNB2 (0.59) | CCNB2CDK1CCNB1CCNB3AURKA | |
| SCHEMBL4921909 | 0.86 | CDK1 (0.43) | CCNB2CDK1CCNB1CCNB3AURKA | |
| SCHEMBL4920209 | 0.85 | AURKA (0.54) | CCNB2CDK1CCNB1CCNB3AURKA | |
| SCHEMBL30850682 | 0.84 | CYP1A2 (0.60) | AURKARPS6KB1AURKBCDC7DBF4 | |
| SCHEMBL4921700 | 0.84 | CYP1A2 (0.60) | AURKARPS6KB1AURKBCDC7DBF4 | |
| SCHEMBL639807 | 0.84 | CDC7 (0.67) | CDK1AURKAAURKBCDC7DBF4 | |
| SCHEMBL621253 | 0.84 | CLK4 (0.67) | AURKARPS6KB1AURKBCDC7DBF4 | |
| SCHEMBL4923417 | 0.84 | EGFR (0.55) | AURKARPS6KB1AURKBCDC7DBF4 | |
| SCHEMBL4921713 | 0.84 | CDC7 (0.48) | AURKAAURKBCDC7DBF4DAPK3 | |
| SCHEMBL1443427 | 0.83 | CDK1 (0.55) | CCNB2CDK1CCNB1CCNB3AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4504948-A1 | COMPOSITIONS AND METHODS FOR TRANSFORMATION OF EMBRYO EXPLANT POPULATIONS | Monsanto Technology LLC (US) | 2025-02-12 | — | — | EP | claimed |
| EP-4472642-A1 | HETEROCYCLIC PURINE CYTOKININ DERIVATIVES, THEIR USE IN WOUND HEALING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES | Univerzita Palackého v Olomouci (CZ) | 2024-12-11 | — | — | EP | claimed |
| EP-4153592-B1 | MESYLATE SALTS OF HETEROCYCLIC CYTOKININS, COMPOSITIONS CONTAINING THESE DERIVATIVES AND USE THEREOF | UNIV PALACKEHO (CZ) | 2024-04-24 | — | — | EP | claimed |
| CN-117796322-A | Culture method for improving browning of paeonia lactiflora callus | 四川省农业科学院经济作物研究所 | 2024-04-02 | — | — | CN | claimed |
| CN-116868889-A | Breeding method of new dendrobium nobile variety | 闽江学院 | 2023-10-13 | — | — | CN | claimed |
| WO-2023196828-A1 | COMPOSITIONS AND METHODS FOR TRANSFORMATION OF EMBRYO EXPLANT POPULATIONS | MONSANTO TECHNOLOGY LLC (US) | 2023-10-12 | — | — | WO | claimed |
| WO-2023078482-A1 | HETEROCYCLIC PURINE CYTOKININ DERIVATIVES, THEIR USE IN WOUND HEALING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES | Univerzita Palackého v Olomouci (CZ) | 2023-05-11 | — | — | WO | claimed |
| CN-113575589-A | Exogenous hormone formula for promoting pumpkin rooting and application method thereof | 安徽省农业科学院园艺研究所 | 2021-11-02 | — | — | CN | claimed |
| US-20050043328-A1 | Heterocyclic compound based on n6-substituted adenine, methods, of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds | USTAV EPERIMENTALNI BOTANIKY AKADEMI VED CESKE REPUBILIKY (CZ) | 2005-02-24 | — | — | US | claimed |
| EP-1419157-A2 | HETEROCYCLIC COMPOUND BASED ON N sp 6 /sp −SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE | Ustav Experimentalni Botaniky Akademie ved Ceské Republiky (CZ) | 2004-05-19 | — | — | EP | claimed |
| WO-2003040144-A2 | HETEROCYCLIC COMPOUND BASED ON N6-SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE COMPOUNDS | USTAV EXPERIMENTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) | 2003-05-15 | — | — | WO | claimed |
| US-12570657-B2 | Mesylate salts of heterocyclic cytokinins, compositions containing these derivatives and use thereof | UNIVERZITA PALACKEHO V OLOMOUCI (CZ) | 2026-03-10 | — | — | US | disclosed |
| EP-4178959-B1 | NITROGEN HETEROCYCLIC CYTOKININ DERIVATIVES, COMPOSITIONS CONTAINING THESE DERIVATIVES AND USE THEREOF | UNIV PALACKEHO (CZ) | 2025-09-10 | — | — | EP | disclosed |
| US-12378247-B2 | Mesylate salt of para-topolin, compositions containing said salt and use thereof | USTAV EXPERIMENTALNI BOTANIKY AV CR, V. V. I. (CZ) | 2025-08-05 | — | — | US | disclosed |
| EP-4504948-A1 | COMPOSITIONS AND METHODS FOR TRANSFORMATION OF EMBRYO EXPLANT POPULATIONS | Monsanto Technology LLC (US) | 2025-02-12 | — | — | EP | disclosed |
| EP-0601092-B1 | METHOD FOR THE SELECTION OF GENETICALLY TRANSFORMED CELLS AND COMPOUNDS FOR USE IN THE METHOD | NOVARTIS AG (CH) | 1999-07-07 | — | — | EP | disclosed |
| EP-0896063-A2 | Method for the selection of genetically transformed cells and compounds for use in the method | Novartis AG (CH) | 1999-02-10 | — | — | EP | disclosed |
| EP-0601092-A1 | METHOD FOR THE SELECTION OF GENETICALLY TRANSFORMED CELLS AND COMPOUNDS FOR USE IN THE METHOD | Novartis AG (CH) | 1994-06-15 | — | — | EP | disclosed |
| WO-1993005163-A1 | METHOD FOR THE SELECTION OF GENETICALLY TRANSFORMED CELLS AND COMPOUNDS FOR USE IN THE METHOD | SANDOZ LTD. (CH) | 1993-03-18 | — | — | WO | disclosed |
| EP-0530129-A1 | Method for the selection of genetically transformed cells and compounds for use in the method | SANDOZ LTD. (CH) | 1993-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043328-A1 | Heterocyclic compound based on n6-substituted adenine, methods, of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds | ATIC, UMPS, CCNB1 | CCNB2 19/4885CDK1 35/4885CCNB1 3/4885 |
| US-12378247-B2 | Mesylate salt of para-topolin, compositions containing said salt and use thereof | TOP2A, TOP1, TOP2B | CCNB2 929/4885CDK1 1913/4885CCNB1 771/4885 |
| US-12570657-B2 | Mesylate salts of heterocyclic cytokinins, compositions containing these derivatives and use thereof | TYMP, TK1, DCK | CCNB2 81/4885CDK1 167/4885CCNB1 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.